Valiant Lab IPO subscribed 2
时间:2024-06-26 17:36:13 阅读(143)
The Initial Public Offering (IPO) of pharmaceutical ingredient manufacturing firm Valiant Laboratories was subscribed 2.17 times on the third day of bidding on Friday.
The initial share sale received bids for 1,65,77,925 shares against 76,23,030 shares on offer, as per NSE data.
Price range for the offer is Rs 133-140 a share.
The IPO is an entirely fresh issuance of up to 1.08 crore equity shares.
Proceeds of the issue will be utilised to set up a manufacturing facility for speciality chemicals in Gujarat through its subsidiary — Valiant Advanced Sciences Private Ltd — and to meet the working capital requirements of the subsidiary company.
Valiant Laboratories is an active pharmaceutical ingredient or bulk drug manufacturing company with its focus on manufacturing paracetamol, used in the treatment of headaches, muscle aches, arthritis, backache, toothache, cold and fever.
Unistone Capital is the manager to the offer.
Equity shares of the company will be listed on the BSE and the NSE.
猜你喜欢
- Gold faces resistance at $2000-2010 amidst mixed market Signals- What next for gold-
- Maldivian govt distances itself from ‘derogatory remarks’ against PM Modi by minister
- Firms, banks float bonds after RBI raises risk weights
- Mahua Moitra’s estranged partner alleges snooping, says calls recorded with help from West Bengal police
- Mahindra & Mahindra shares jump 3
- FII, DII data- FPIs sold shares worth Rs 190 Cr, DIIs added shares worth Rs 95 Cr on November 12, Sunday
- Markets end in positive zone after volatile session; realty and banks shine even as IT and pharma struggle
- Markets end higher on November 29; top gainers include Axis Bank, Hero MotoCorp, Mahindra & Mahindra, while Financial Services and Media stocks are among the key losers
- Gold near oversold zone, traders waiting for directional cues; be safe on trade, avoid taking any positions